Axial Therapeutics announced that it is building on its clinical development science and operations capabilities through recent key appointments....

Read more
By: Kairos Ventures On: October 10, 2022 In: MemVerge, Portfolio News

Bio-IT World has announced the entries in our first Bio-IT World Europe Best of Show Awards. Entries from Dassault...

Read more

Axial Therapeutics Inc. announced that A. Stewart Campbell, Ph.D., Chief Executive Officer, will present in two seminars at BioJapan...

Read more
By: Kairos Ventures On: September 30, 2022 In: FGC Plasma Solutions, Portfolio News

FGC Plasma Solutions partners with UVA's Hypersonic Project to provide an essential piece of highly specialized equipment - plasma...

Read more
By: Kairos Ventures On: September 29, 2022 In: Portfolio News, Vivodyne

The U.S. Senate unanimously passed the FDA Modernization Act 2.0, S.5002 on September 28. As we shared last month,...

Read more
By: Kairos Ventures On: September 21, 2022 In: Linnaeus, Portfolio News

Linnaeus Therapeutics, Inc. announced that on June 28, 2022 the U.S. Patent and Trademark Office (USPTO) issued U.S. patent 11,369,618 ('618...

Read more
By: Kairos Ventures On: September 13, 2022 In: Axial Therapeutics, Portfolio News

Axial Therapeutics announced that A. Stewart Campbell, Ph.D., will participate in a panel entitled “The Next Wave of Targeted...

Read more
By: Kairos Ventures On: September 12, 2022 In: Linnaeus, Portfolio News

Linnaeus Therapeutics announced the presentation of clinical biomarker data from its study of LNS8801 as a monotherapy and in...

Read more
By: Kairos Ventures On: September 8, 2022 In: Portfolio News, Vivodyne

Dr. Jane Goodall and Vivodyne announced that they have delivered a letter to Congress urging its inclusion of the...

Read more
By: Kairos Ventures On: August 4, 2022 In: MemVerge, Portfolio News

Flash Memory Summit (FMS) is pleased to announce its 2022 Best of Show Award winners. This year's awards recognize...

Read more